anmelden
SXI Life Sciences
7.772,36
PKT
-3,32
PKT
-0,04
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Leider sind zu diesem Wert keine aktuellen Kursdaten verfügbar, die Stammdaten finden Sie im unteren Seitenbereich.
Analysen zu SXI Life Sciences-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 11.05.22 | Roche Neutral | JP Morgan Chase & Co. | |
| 11.05.22 | Roche Sell | UBS AG | |
| 11.05.22 | Roche Buy | Jefferies & Company Inc. | |
| 05.05.22 | Roche Buy | Jefferies & Company Inc. | |
| 05.05.22 | Novartis Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 28.04.22 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 27.04.22 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 27.04.22 | Novartis Neutral | Credit Suisse Group | |
| 27.04.22 | Novartis Underweight | JP Morgan Chase & Co. | |
| 27.04.22 | Novartis Neutral | UBS AG | |
| 27.04.22 | Novartis Sell | Deutsche Bank AG | |
| 26.04.22 | Novartis Neutral | UBS AG | |
| 26.04.22 | Roche Neutral | Credit Suisse Group | |
| 26.04.22 | Roche Buy | Deutsche Bank AG | |
| 26.04.22 | Roche Overweight | Barclays Capital | |
| 26.04.22 | Novartis Buy | Jefferies & Company Inc. | |
| 26.04.22 | Novartis Underweight | JP Morgan Chase & Co. | |
| 25.04.22 | Roche Outperform | Bernstein Research | |
| 25.04.22 | Roche Sell | UBS AG | |
| 25.04.22 | Roche Neutral | JP Morgan Chase & Co. | |
| 25.04.22 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 22.04.22 | Novartis Underweight | JP Morgan Chase & Co. | |
| 19.04.22 | Roche Buy | Jefferies & Company Inc. | |
| 19.04.22 | Novartis Buy | Jefferies & Company Inc. | |
| 19.04.22 | Roche Neutral | JP Morgan Chase & Co. | |
| 19.04.22 | Roche Sell | UBS AG | |
| 13.04.22 | Roche Equal-weight | Morgan Stanley | |
| 12.04.22 | Roche Neutral | JP Morgan Chase & Co. | |
| 12.04.22 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 08.04.22 | Novartis Neutral | UBS AG | |
| 05.04.22 | Novartis Sell | Deutsche Bank AG | |
| 04.04.22 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 04.04.22 | Novartis Underweight | JP Morgan Chase & Co. | |
| 01.04.22 | Novartis Underweight | JP Morgan Chase & Co. | |
| 31.03.22 | Roche Buy | Deutsche Bank AG | |
| 30.03.22 | Roche Overweight | Barclays Capital | |
| 30.03.22 | Roche Buy | Merrill Lynch & Co., Inc. | |
| 30.03.22 | Roche Neutral | JP Morgan Chase & Co. | |
| 30.03.22 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 30.03.22 | Roche Outperform | Bernstein Research |